Head of Investor Relations
Ptc Therapeutics, Inc. (PTCT)Head of Investor Relations
Praxis Precision Medicines, Inc. (PRAX)Equibles does not estimate personal net worth.
Get an email with a short summary when Ptc Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get PTCT alertsAlex Kane is recorded as Head of Investor Relations at Ptc Therapeutics, Inc. (PTCT) and Head of Investor Relations at Praxis Precision Medicines, Inc. (PRAX). Alex Kane has spoken on 3 earnings calls across 2 companies, most recently for Praxis Precision Medicines, Inc. on May 9, 2022. Those appearances were for Praxis Precision Medicines, Inc. (PRAX) and Ptc Therapeutics, Inc. (PTCT). Praxis Precision Medicines, Inc. is classified in the Biotechnology industry within the Healthcare sector. Ptc Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Praxis Precision Medicines, Inc. includes Marcio Souza (CEO and Board Member), Timothy E. Kelly (CFO), Timothy Kelly (CFO) and 7 others.
“Good afternoon, everyone, and thank you for joining us today for our first-quarter 2022 corporate update Q&A call. With me on the call is our President and Chief Executive Officer, Marcio Souza, our Chief Medical Officer, Bernard Ravina, and our CFO, Tim Kelly.”
“And thank you for joining us today for our Fourth Quarter of fiscal year 2021 corporate update Q&A call. With me on the call is our President and CEO, Marcio Souza, our Chief Medical Officer, Bernard Ravina, and our Chief Financial Officer, Tim Kelly.”
“Good afternoon, and thank you for joining us to discuss PTC Therapeutics’ second quarter 2020 corporate update and financial results.”
Biotechnology · Healthcare
Head of Investor Relations
Biotechnology · Healthcare
Head of Investor Relations
